Background: Role of vitamin K antagonist (VKA) or Direct Oral anticoagulation (DOAC) for non-valvular atrial fibrillation has widely been discussed. But the literature on anticoagulation therapy for patients with valvular atrial fibrillation (VAF) is limited. Aim of this meta-analysis was to evaluate the outcomes (stroke-vascular events and intracranial bleeding) following DOAC and VKA amongst patients [...]

Case Presentation: We present an 80-year-old female with a medical history significant for atrial fibrillation and heart failure with preserved ejection fraction. She underwent pulmonary vein isolation in 2017 and had reportedly been on flecainide 150 mg twice daily and atenolol 100 milligram twice daily since then. She presented to the emergency department with dyspnea [...]

Background: Accurate documentation of the patient’s diagnoses helps to reflect the severity of illness which has several downstream impacts: clinical outcomes data, risk stratification, hospital quality metrics data such as readmission and mortality index, hospital reimbursement. For this reason, our health system has various ongoing initiatives on clinical documentation to improve the specification of certain [...]

Case Presentation: A 62-year-old male with no significant medical history presented to our clinic after new diagnosis of atrial fibrillation. He had no associated symptoms and endorsed great exercise tolerance. Transthoracic echocardiogram (TTE) was ordered and he was started on metoprolol 25 milligram two times daily. TTE demonstrated normal global systolic function with severely dilated [...]

Background: Atrial fibrillation (AF) is condition associated with increased risk of death in multiple populations (1). The association between AF and COVID-19 infection has started to be explored, but largely in specific geographic locations and/or within the context of the hospitalization (2). By understanding the relationship between COVID-19 and AF, providers may be better supported [...]